Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on Immunotherapy in Lung Cancer July 2019

03 - 04 Jul 2019

Zurich, Switzerland

ESMO Advanced Course on Lung Cancer 1000x1000

Presentations from all ESMO Advanced Courses are open to all according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Learning objectives

  • Understanding the key players in tumour immunology
  • Getting up-to-date on the role of immunotherapy in advanced NSCLC
  • The role of biomarkers in selecting NSCLC patients for IT
  • Why should angiogenesis inhibition be combined with Check-Point Inhibitors
  • How to manage IT toxicity and how to use IT in specific subgroups of patients 

 

Hide
Filter by:

There are 11 resources available

Welcome and introduction

Presenter: John Haanen

Session: Welcome and introduction

Resources:

Presentation

Webcast

Debate Pro: one size fits all!

Presenter: Maurice Pérol

Session: Session 2: Are all fit patients candidates for 1st-line treatment with Immune Check Point Inhibitors?

Resources:

Presentation

Webcast

The point of view of the Immunologist

Presenter: John Haanen

Session: Session 5: Refining patient selection: Immuno-score, -profiling, -gram and Tumor Mutation Burden

Resources:

Presentation

Webcast

Brain metastasis as a target

Presenter: Aurélien Marabelle

Session: Session 6: Efficacy evaluation of Immune Check Points Inhibitors: Recist 1.1, iRecist or Ir Recist? The issue and risk of hyper-progression

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings